Cost-effective analysis of different algorithms for the diagnosis of hepatitis C virus infection

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 2, 2008, Pages 126-134

  Barreto, A M E C ^a,b   Takei, K ^a   Sabino, E C ^b   Bellesa, M A O ^b   Salles, N A ^b   Barreto, C C ^b   Nishiya, A S ^b   Chamone, D F ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

Author keywords

Algorithm; Diagnosis; ELISA; Hepatitis C virus; Immunoblot; Polymerase chain reaction

Indexed keywords

ALGORITHM; ARTICLE; BRAZIL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HUMAN; IMMUNOBLOTTING; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; SERODIAGNOSIS; VIREMIA;

HEPATITIS C VIRUS;

EID: 41149146957     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2008005000004     Document Type: Article

References (28)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362.
2. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-364.
3. Gretch DR. Diagnostic tests for hepatitis C. Hepatology 1997; 26: 43S-47S.
4. Neville JA, Prescott LE, Bhattacherjee V, Adams N, Pike I, Rodgers B, et al. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus. J Clin Microbiol 1997; 35: 3062-3070.
5. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao, F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-562.
6. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 1691-1696.
7. Centers for Disease Control and Prevention (CDC). Hepatitis C virus infection among firefighters, emergency medical technicians, and paramedics - selected locations, United States, 1991-2000. Morb Mortal Wkly Rep 2000; 49: 660-665.
8. Centers for Disease Control and Prevention (CDC). Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Morb Mortal Wkly Rep 2003; 52: 1-15.
9. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002; 36: S21-S29.
10. Gonçales NS, Costa FF, Vassallo J, Gonçales FL Jr. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay. Rev Inst Med Trop São Paulo 2000; 42: 263-267.
11. Barreto AMEC, Takei K, Sabino EC, Salles NA, Barreto CC, Nishiya AS, et al. Análise do custo beneficio dos diferentes algoritmos para o diagnóstico da infecção pelo HCV. Annals of Congresso Brasileiro de Patologia Clinica/Medicinal Laboratorial. 2004, p 38 (Abstract).
12. Bossi V, Galli C. Quantitative signal of anti-HCV by an automated assay predicts viremia in a populatioh at high prevalence of hepatitis C virus infection. J Clin Virol 2004; 30: 45-49.
13. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993, 74 (Part 6): 1093-1102.
14. Stuyver L, Wyseur A, van Arnhem W, Hernandez F, Maertens G. Second-generation line probe assay for hepatitis C virus genotyping. J Clin Microbiol 1996; 34: 2259-2266.
15. VQC proficiency programme for viral NAT assays in 2000. The Viral Quality Control (VQC) laboratory, The National Serology Reference Laboratory, The Delft Diagnostic Laboratory, organized [Cited Aug 27, 2007]. Viral Quality Control (VQC) laboratory http://www.inmunochem.com/descargar/VQC_2000.pdf; 2007.
16. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002 - June 10-12, 2002. Hepatology 2002; 36: S3-S20.
17. Oethinger M, Mayo DR, Falcone J, Barua PK, Griffith BP. Efficiency of the ortho VITROS assay for detection of hepatitis C virus-specific antibodies increased by elimination of supplemental testing of samples with very low sample-to-cut-off ratios. J Clin Microbiol 2005; 43: 2477-2480.
18. Ren FR, Lv QS, Zhuang H, Li JJ, Gong XY, Gao GJ, et al. Significance of the signal-to-cut-off ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors. Transfusion 2005; 45: 1816-1822.
19. Kiely P, Kay D, Parker S, Piscitelli L. The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays. Transfusion 2004; 44: 349-358.
20. Kleinman SH, Stramer SL, Brodsky JP, Caglioti S, Busch MP. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms. Transfusion 2006; 46: 695-702.
21. Kondili LA, Chionne P, Costantino A, Villano U, Lo Noce C, Pannozzo F, et al. Infection rate and spontaneous serore-version of anti-hepatitis in the general population. Gut 2002; 50: 693-696.
22. Bassit L, Da Silva LC, Ribeiro-Dos-Santos G, Maertens G, Carrilho FJ, Fonseca LE, et al. Chronic hepatitits C virus infections in Brazillian patients: associetion with genotypes, clinical parameters and response to long-term alpha interferon therapy. Rev Inst Med Trop São Paulo 1999; 41: 183-189.
23. Zachary P, Ullmann M, Djeddi S, Meyer N, Wendling MJ, Schvoerer E, et al. Evaluation of three commercially available hepatitis C virus antibody detection assays under the conditions of a clinical virology laboratory. J Clin Virol 2005; 34: 207-210.
24. Busch MP. Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients. Transfus Clin Biol 2001; 8: 200-206.
25. Feucht HH, Zollner B, Polywka S, Laufs R. Study on reliability of commercially available hepatitis C virus antibody tests. J Clin Microbiol 1995; 33: 620-624.
26. Simon N, Courouce AM, Lemarrec N, Trepo C, Ducamp S. A twelve year natural, history of hepatitis C virus infection in hemodialyzed patients. Kidney Int 1994; 46: 504-511.
27. Lefrere JJ, Guiramand S, Lefrere F, Mariotti M, Aumont P, Lerable J, et al. Full or partial seroreversion in patients infected by hepatitis C virus. J Infect Dis 1997; 175: 316-322.
28. Poignet JL, Degos F, Bouchardeau F, Chauveau P, Courouce AM. Complete response to interferon-alpha for acute hepatitis C after needlestick injury in a hemodialysis nurse. J Hepatol 1995; 23: 740-741.